Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Gains from Investment Securities (2016 - 2025)

Prestige Consumer Healthcare has reported Gains from Investment Securities over the past 16 years, most recently at $44000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $44000.0 for Q4 2025, down 99.26% from a year ago — trailing twelve months through Dec 2025 was -$1.8 million (down 129.79% YoY), and the annual figure for FY2025 was -$234000.0, changed.
  • Gains from Investment Securities for Q4 2025 was $44000.0 at Prestige Consumer Healthcare, down from $3.6 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PBH hit a ceiling of $5.9 million in Q4 2024 and a floor of -$6.1 million in Q1 2025.
  • Median Gains from Investment Securities over the past 5 years was $608000.0 (2025), compared with a mean of $587052.6.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 6619.32% in 2023 and later tumbled 2725.97% in 2025.
  • Prestige Consumer Healthcare's Gains from Investment Securities stood at -$1.6 million in 2021, then surged by 77.59% to -$353000.0 in 2022, then soared by 1111.05% to $3.6 million in 2023, then skyrocketed by 65.73% to $5.9 million in 2024, then crashed by 99.26% to $44000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $44000.0 (Q4 2025), $3.6 million (Q3 2025), and $608000.0 (Q2 2025) per Business Quant data.